Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| GUN | Gunsynd | AIM | £1.4M | 0.08 | 9.50% | |
| VAL | ValiRx | AIM | £1.98M | 0.16 | -2.20% | |
| FUM | Futura Medical | AIM | £2.2M | 0.41 | 14.60% | |
| OBD | Oxford BioDynamics | AIM | £4.93M | 0.11 | -4.00% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| OPTI | OptiBiotix Health | AIM | £5.94M | 5.50 | -3.30% | |
| PRM | Proteome Sciences | AIM | £6.31M | 1.80 | 8.00% | |
| VRCI | Verici Dx | AIM | £6.86M | 0.24 | -4.80% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| GDR | Genedrive | AIM | £16.86M | 1.05 | -1.60% | |
| IXI | Ixico | AIM | £17.99M | 7.50 | -1.50% | |
| EDEN | Eden Research | AIM | £21.29M | 2.51 | -2.40% | |
| IMM | ImmuPharma | AIM | £23.08M | 3.58 | -3.00% | |
| AREC | Arecor Therapeutics | AIM | £23.98M | 60.90 | -1.30% | |
| SAR | Sareum Holdings | AIM | £29.1M | 23.74 | -5.60% | |
| SBTX | SkinBioTherapeutics | AIM | £30.45M | 11.15 | -14.90% | |
| ABDX | Abingdon Health | AIM | £44.59M | 10.33 | 2.60% | |
| STX | Shield Therapeutics | AIM | £47.01M | 3.90 | -7.90% | |
| POLB | Poolbeg Pharma | AIM | £48.86M | 6.70 | -2.10% | |
| HVO | Hvivo | AIM | 2.58 | £53.24M | 7.40 | -5.10% |
| ANIC | Agronomics | AIM | £60.89M | 5.61 | -0.60% | |
| EAH | Eco Animal Health Group | AIM | £65.73M | 101.00 | -4.30% | |
| OBI | Ondine Biomedical Inc | AIM | £71.44M | 13.50 | 2.60% | |
| BVXP | Bioventix | AIM | 9.93 | £78.9M | 1,506.00 | -2.20% |
| 4BB | 4basebio | AIM | £81.58M | 519.75 | -0.40% | |
| FARN | Faron Pharmaceuticals OY | AIM | £94.23M | 42.30 | 1.10% | |
| ANP | Anpario | AIM | 2.36 | £107.22M | 529.00 | -0.90% |
| DXRX | Diaceutics | AIM | £115.57M | 143.50 | -0.50% | |
| SCLP | Scancell Holdings | AIM | £118.8M | 9.75 | -1.10% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BTG | BTG | AIM | 4.32 | £171.74M | 106.00 | -0.10% |
| ANCR | Animalcare Group | AIM | 0.66 | £231.3M | 335.00 | -2.60% |
| PRTC | Puretech Health | FTSE Small Cap | £291.7M | 119.00 | -0.50% | |
| AVCT | Avacta Group | AIM | £318.05M | 67.90 | -7.00% | |
| AGY | Allergy Therapeutics | AIM | £344.49M | 5.98 | -2.50% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £683.87M | 560.00 | -0.88% | |
| HCM | Hutchmed China | AIM | £1.46B | 170.00 | 4.80% | |
| GNS | Genus | FTSE 250 | 1.43 | £1.49B | 2,194.00 | -2.23% |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 3.92 | £3.36B | 1,585.00 | -0.56% |
| HLN | Haleon | FTSE 100 | 1.93 | £32.47B | 363.30 | -1.44% |
| GSK | GSK | FTSE 100 | 3.71 | £78.48B | 1,931.50 | -0.44% |
| AZN | AstraZeneca | FTSE 100 | 1.88 | £197.29B | 12,632.00 | -0.69% |